Cargando…
High baseline prevalence of atopic comorbidities and medication use in children treated with allergy immunotherapy in the REAl-world effeCtiveness in allergy immunoTherapy (REACT) study
BACKGROUND: Respiratory allergy, commonly manifesting as allergic rhinitis (AR) and asthma, is a chronic progressive disease that frequently starts in childhood. Allergy immunotherapy (AIT) is the only causal treatment for respiratory allergy with the potential to modify the underlying cause of alle...
Autores principales: | Fritszching, Benedikt, Porsbjerg, Celeste, Buchs, Sarah, Larsen, Julie Rask, Freemantle, Nick, Contoli, Marco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10098718/ https://www.ncbi.nlm.nih.gov/pubmed/37063677 http://dx.doi.org/10.3389/fped.2023.1136942 |
Ejemplares similares
-
Long-term real-world effectiveness of allergy immunotherapy in patients with allergic rhinitis and asthma: Results from the REACT study, a retrospective cohort study.
por: Fritzsching, Benedikt, et al.
Publicado: (2021) -
Need for longitudinal studies to assess the real-world effectiveness of allergy immunotherapy in patients with allergic rhinitis and asthma – Authors´ reply
por: Fritzsching, Benedikt, et al.
Publicado: (2022) -
Update on Allergy Immunotherapy
por: Davidson, William, et al.
Publicado: (2005) -
Debates in allergy medicine: specific immunotherapy efficiency in children with atopic dermatitis
por: Slavyanakaya, Tatiana A., et al.
Publicado: (2016) -
Debates in allergy medicine: Specific immunotherapy in children with atopic dermatitis, the “con” view
por: Ginsberg, David N., et al.
Publicado: (2016)